GVK Biosciences (GVK BIO), Asia’s leading research services organization, recently conducted a media workshop ‘Demystifying Clinical Trials’ at its Clinical Pharmacology Facility in Ameerpet in Hyderabad.
The objective of the Workshop was to take participating journalists through Drug Development, the Clinical Research process (how clinical trials are set up, conducted and completed) and Systems of Human Subject/Volunteer protection. It was primarily aimed at providing healthcare journalists with a good understanding of the drug discovery and development process thus enabling greater appreciation of the context in which clinical trials/bioequivalence studies are conducted. Issues related to human subject protection were the main focus of the Workshop. This was followed by a site visit of the GVK BIO Bioequivalence Facility Tour.
Speaking on the occasion Mr. Manni Kantipudi, President, GVK Biosciences said, “We believe that media plays an important role in highlighting the core issues concerning public and this session was to take them through the processes involved in conducting trials.”Dr. Mukherjee said that, “It is important to ensure that the trials are conducted in a most ethical manner and we at GVK BIO strive to provide the best clinical development services to our clients in India and globally.”
This interactive workshop ‘Demystifying Clinical Trials in India’ was very well received and the level of participation quite encouraging. Dr. Shoibal Mukherjee, Senior Vice President – Clinical Development, GVK BIO and Dr. Sailendra Goswami, Vice President – M&A, Clinical Pharmacology, GVK BIO shared their views on drug development, clinical trials and bioequivalence studies and highlighted the best practices adopted by the leading Contract Research Organizations such as GVK BIO to ensure highest safety ofsubjects/volunteers involved in the processes.
GVK BIO plans to hold such workshops in other areas of life‐sciences too and also have updates on a regular basis for the media.
The objective of the Workshop was to take participating journalists through Drug Development, the Clinical Research process (how clinical trials are set up, conducted and completed) and Systems of Human Subject/Volunteer protection. It was primarily aimed at providing healthcare journalists with a good understanding of the drug discovery and development process thus enabling greater appreciation of the context in which clinical trials/bioequivalence studies are conducted. Issues related to human subject protection were the main focus of the Workshop. This was followed by a site visit of the GVK BIO Bioequivalence Facility Tour.
Speaking on the occasion Mr. Manni Kantipudi, President, GVK Biosciences said, “We believe that media plays an important role in highlighting the core issues concerning public and this session was to take them through the processes involved in conducting trials.”Dr. Mukherjee said that, “It is important to ensure that the trials are conducted in a most ethical manner and we at GVK BIO strive to provide the best clinical development services to our clients in India and globally.”
This interactive workshop ‘Demystifying Clinical Trials in India’ was very well received and the level of participation quite encouraging. Dr. Shoibal Mukherjee, Senior Vice President – Clinical Development, GVK BIO and Dr. Sailendra Goswami, Vice President – M&A, Clinical Pharmacology, GVK BIO shared their views on drug development, clinical trials and bioequivalence studies and highlighted the best practices adopted by the leading Contract Research Organizations such as GVK BIO to ensure highest safety ofsubjects/volunteers involved in the processes.
GVK BIO plans to hold such workshops in other areas of life‐sciences too and also have updates on a regular basis for the media.
